Back to top

Image: Bigstock

Ryan Specialty (RYAN) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

Read MoreHide Full Article

For the quarter ended June 2026, Ryan Specialty Group (RYAN - Free Report) reported revenue of $916.65 million, up 7.2% over the same period last year. EPS came in at $0.74, compared to $0.66 in the year-ago quarter.

The reported revenue represents a surprise of +4.91% over the Zacks Consensus Estimate of $873.71 million. With the consensus EPS estimate being $0.61, the EPS surprise was +21.31%.

While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.

As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.

Here is how Ryan Specialty performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:
  • Revenue- Fiduciary investment income: $13.92 million compared to the $12.44 million average estimate based on four analysts.
  • Revenue- Net commissions and fees: $902.73 million versus $863.25 million estimated by four analysts on average.
  • Revenue- Net commissions and fees- Binding Authority: $100.17 million compared to the $95.94 million average estimate based on two analysts.
  • Revenue- Net commissions and fees- Underwriting Management: $303.76 million versus $302.82 million estimated by two analysts on average.
  • Revenue- Net commissions and fees- Wholesale Brokerage: $498.8 million versus $465.24 million estimated by two analysts on average.

View all Key Company Metrics for Ryan Specialty here>>>

Shares of Ryan Specialty have returned +16.1% over the past month versus the Zacks S&P 500 composite's -1.5% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.

Published in